Friday - December 26, 2025
AskBio's AB-1005 and AB-1002 Receive Pioneering Regenerative Medical Product Designation in Japan
December 09, 2025
LEVERKUSEN, Germany, Dec. 9 -- Bayer, a pharmaceutical and life sciences company, issued the following news release:

* * *

AskBio's AB-1005 and AB-1002 Receive Pioneering Regenerative Medical Product Designation in Japan

Product designation supports development of innovative investigational gene therapies for Parkinson's disease and congestive heart failure

*

AskBio Inc., a gene therapy company wholly owned and independen . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products